- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
SomnoMed Ltd (SOM)
SomnoMed Ltd stock price live, this page displays ASX SOM stock exchange data. View the SOM premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the SomnoMed Ltd real time stock price chart below.
What Is the SomnoMed Ltd Stock Price Today?
The SomnoMed Ltd stock price today is 0.300.
What Is the Stock Symbol for SomnoMed Ltd?
The stock symbol for SomnoMed Ltd is "SOM."
What Stock Exchange Does SomnoMed Ltd Trade On?
SomnoMed Ltd is listed and trades on the Sydney stock exchange.
Is SomnoMed Ltd a Good Stock to Buy?
Determining whether SomnoMed Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SOM quote. (ISIN: AU000000SOM1)
What Is the SomnoMed Ltd Stock Price Today?
The SomnoMed Ltd stock price today is 0.300.
What Is the Stock Symbol for SomnoMed Ltd?
The stock symbol for SomnoMed Ltd is "SOM."
What Stock Exchange Does SomnoMed Ltd Trade On?
SomnoMed Ltd is listed and trades on the Sydney stock exchange.
Is SomnoMed Ltd a Good Stock to Buy?
Determining whether SomnoMed Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SOM quote. (ISIN: AU000000SOM1)
0.300
+0.005(+1.69%)
Delayed Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.300
0.300
52 wk Range
0.290
0.945
SOM is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.3000.300
52 wk Range
0.2900.945
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
SOM Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
0.837
Upside
+178.89%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 0.837
(+178.89% Upside)
SomnoMed Ltd Earnings Call Summary for H2/2026
- SomnoMed reported FY 2026 revenue up 3% to AUD 114.5M; EBITDA rose 19% to AUD 10.9M with margin improving to 9.6% from 8.2%.
- Growth split sharply: H1 revenue up 13%, H2 down 7% due to European reimbursement headwinds and stronger Australian dollar impact.
- North America remained key growth driver with 6% reported revenue growth, 11% in constant currency; Europe faced tougher market conditions.
- Management targets high single-digit revenue growth for FY 2027 with stable EBITDA margins; detailed outlook deferred to November AGM.
- Virtus oral appliance and Rest Assure platform highlighted as growth catalysts; shares flat at $0.33, bottom of 52-week range.
Last Updated: 08/28/2026, 09:10 AM
Read Full TranscriptEarnings
Latest Release
Aug 27, 2026
EPS / Forecast
-0.02 / 10.00
Revenue / Forecast
53.82M / --
Compare SOM to Peers and Sector
Metrics to compare | SOM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSOMPeersSector | |
|---|---|---|---|---|
P/E Ratio | −24.5x | −3.2x | −0.3x | |
PEG Ratio | −0.98 | −0.08 | 0.00 | |
Price/Book | 1.4x | 5.9x | 2.6x | |
Price / LTM Sales | 0.6x | 3.7x | 3.0x | |
Upside (Analyst Target) | 183.6% | 73.5% | 56.4% | |
Fair Value Upside | Unlock | 4.1% | 7.2% | Unlock |
SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. The company offers SomnoDent, such as SomnoDent Avant, SomnoDent Classic, SomnoDent Flex, herbst advance, and SomnoDent Fusion for the treatment of obstructive sleep apnea. It also provides SomMorning Repositioner, a product designed to help return patient’s mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient’s upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs, which are cleaning tablets to clean oral appliances. SomnoMed Limited was incorporated in 1987 and is headquartered in Crows Nest, Australia.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the SomnoMed Ltd (SOM) Stock Price Today?
The SomnoMed Ltd stock price today is 0.300 AUD.
What Stock Exchange Does SomnoMed Ltd Trade On?
SomnoMed Ltd is listed and trades on the Sydney Stock Exchange.
What Is the Stock Symbol for SomnoMed Ltd?
The stock symbol for SomnoMed Ltd is "SOM."
What Is the SomnoMed Ltd Market Cap?
As of today, SomnoMed Ltd market cap is 65.930M AUD.
What Is SomnoMed Ltd's Earnings Per Share (TTM)?
The SomnoMed Ltd EPS (TTM) is -0.012.
When Is the Next SomnoMed Ltd Earnings Date?
SomnoMed Ltd will release its next earnings report on Dec 02, 2026.
From a Technical Analysis Perspective, Is SOM a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has SomnoMed Ltd Stock Split?
SomnoMed Ltd has split 5 times.
How Many Employees Does SomnoMed Ltd Have?
SomnoMed Ltd has 300 employees.
What is the current trading status of SomnoMed Ltd (SOM)?
As of Oct 01, 2026, SomnoMed Ltd (SOM) is trading at a price of 0.300 AUD, with a previous close of 0.295 AUD. The stock has fluctuated within a day range of 0.300 AUD to 0.300 AUD, while its 52-week range spans from 0.290 AUD to 0.945 AUD.
What Is SomnoMed Ltd (SOM) Price Target According to Analysts?
The average 12-month price target for SomnoMed Ltd is 0.837 AUD, with a high estimate of 0.99 AUD and a low estimate of 0.76 AUD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +178.89% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.